G. Rube?a, L. Gudelj, and N. Kubinska, Etiology of schizophrenia and therapeutic options, Psychiatr Danub, vol.23, pp.308-323, 2011.

R. Tandon, M. S. Keshavan, H. A. Nasrallah, and . Schizophrenia, Just the Facts" What we know in 2008. 2. Epidemiology and etiology, Schizophr Res, vol.102, pp.1-18, 2008.

J. A. Gogos and D. J. Gerber, Schizophrenia susceptibility genes: emergence of positional candidates and future directions, Trends Pharmacol Sci, vol.27, pp.226-259, 2006.

T. J. Crow, The emperors of the schizophrenia polygene have no clothes, Psychol Med, vol.38, pp.1681-1686, 2008.

M. S. Farrell, T. Werge, P. Sklar, M. J. Owen, R. A. Ophoff et al., Evaluating historical candidate genes for schizophrenia, Mol Psychiatry, vol.20, issue.5, p.555, 2015.

P. Lichtenstein, B. H. Yip, C. Björk, Y. Pawitan, T. D. Cannon et al., Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study, Lancet, vol.373, issue.9659, pp.60072-60078, 2009.

P. F. Sullivan, K. S. Kendler, and N. Mc, Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies, Arch Gen Psychiatry, vol.60, pp.1187-1189, 2003.

N. R. Wray and I. I. Gottesman, Using summary data from the danish national registers to estimate heritabilities for schizophrenia, bipolar disorder, and major depressive disorder, Front Genet, vol.3, p.118, 2012.

D. H. Kavanagh, K. E. Tansey, M. C. O'donovan, and M. J. Owen, Schizophrenia genetics: emerging themes for a complex disorder, Mol Psychiatry, vol.20, issue.1, p.72, 2015.

A. Caspi and T. E. Moffitt, Gene-environment interactions in psychiatry: joining forces with neuroscience, Nat Rev Neurosci, vol.7, pp.583-90, 2006.

F. A. Champagne, Early environments, glucocorticoid receptors, and behavioral epigenetics, Behav Neurosci, vol.127, pp.628-664, 2013.

L. S. Kegeles, A. Abi-dargham, W. G. Frankle, R. Gil, T. B. Cooper et al., Increased synaptic dopamine function in associative regions of the striatum in schizophrenia, Arch Gen Psychiatry, vol.67, issue.3, pp.231-240, 2010.

D. S. Manoach, Prefrontal cortex dysfunction during working memory performance in schizophrenia: reconciling discrepant findings, Schizophr Res, vol.60, pp.285-293, 2003.

C. A. Tamminga, A. D. Stan, and A. D. Wagner, The hippocampal formation in schizophrenia, Am J Psychiatry, vol.167, pp.1178-93, 2010.

M. M. Darby, R. H. Yolken, and S. Sabunciyan, Consistently altered expression of gene sets in postmortem brains of individuals with major psychiatric disorders, Transl Psychiatry, vol.6, pp.890-890, 2016.

P. Roussos, P. Katsel, K. L. Davis, L. J. Siever, and V. Haroutunian, A systemlevel transcriptomic analysis of schizophrenia using postmortem brain tissue samples, Arch Gen Psychiatry, vol.69, p.1205, 2012.

R. A. Piskorowski, K. Nasrallah, A. Diamantopoulou, J. Mukai, S. I. Hassan et al., Age-dependent specific changes in area CA2 of the hippocampus and social memory deficit in a mouse model of the 22q11. 2 deletion syndrome, Neuron, vol.89, issue.1, pp.163-76, 2016.

M. Fromer, P. Roussos, S. K. Sieberts, J. S. Johnson, D. H. Kavanagh et al., Gene expression elucidates functional impact of polygenic risk for schizophrenia, Nat Neurosci, vol.19, issue.11, p.1442, 2016.

S. E. Hemby, S. D. Ginsberg, B. Brunk, S. E. Arnold, J. Q. Trojanowski et al., Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex, Arch Gen Psychiatry, vol.59, issue.7, pp.631-671, 2002.

P. R. Maycox, F. Kelly, A. Taylor, S. Bates, J. Reid et al., Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function, Mol Psychiatry, vol.14, issue.12, p.1083, 2009.

T. A. Lanz, V. Reinhart, M. J. Sheehan, S. Rizzo, S. E. Bove et al., Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder, Transl Psychiatry, vol.9, p.151, 2019.

T. A. Lanz, J. J. Joshi, V. Reinhart, K. Johnson, L. Grantham et al., STEP levels are unchanged in pre-frontal cortex and associative striatum in postmortem human brain samples from subjects with schizophrenia, bipolar disorder and major depressive disorder, PloS One, vol.10, issue.3, p.121744, 2015.

E. Antonova, T. Sharma, R. Morris, and V. Kumari, The relationship between brain structure and neurocognition in schizophrenia: a selective review, Schizophr Res, vol.70, issue.2-3, pp.117-162, 2004.

G. Orellana and A. Slachevsky, Executive functioning in schizophrenia, Front Psychiatry, vol.4, p.35, 2013.

E. H. Simpson, C. Kellendonk, and E. Kandel, A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia, Neuron, vol.65, pp.585-96, 2010.

J. A. Lieberman, R. R. Girgis, G. Brucato, H. Moore, F. Provenzano et al., Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention, Mol Psychiatry, vol.23, pp.1764-1766, 2018.

M. Faiz, L. Acarin, B. Castellano, and B. Gonzalez, Proliferation dynamics of germinative zone cells in the intact and excitotoxically lesioned postnatal rat brain, BMC Neurosci, vol.6, p.26, 2005.

K. Mirnics, F. A. Middleton, A. Marquez, D. A. Lewis, and P. Levitt, Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex, Neuron, vol.28, pp.85-89, 2000.

A. Giersch, P. E. Poncelet, R. L. Capa, B. Martin, C. Z. Duval et al., Disruption of information processing in schizophrenia: the time perspective, Schizophr Res, vol.2, issue.2, pp.78-81, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02061233

A. Hershko and A. Ciechanover, The ubiquitin system, Annu Rev Biochem, vol.67, pp.425-434, 1998.

L. Enriquez-barreto and M. Morales, The PI3K signaling pathway as a pharmacological target in Autism related disorders and Schizophrenia, Mol Cell Ther, vol.4, p.1, 2016.

P. Bubber, J. Tang, V. Haroutunian, H. Xu, K. L. Davis et al., Mitochondrial enzymes in schizophrenia, J Mol Neurosci, vol.24, issue.2, pp.315-336, 2004.

E. S. Emamian, M. Karayiorgou, and J. A. Gogos, Decreased phosphorylation of NMDA receptor type 1 at serine 897 in brains of patients with Schizophrenia, J Neurosci, vol.24, pp.1561-1565, 2004.

S. Prabakaran, J. E. Swatton, M. M. Ryan, S. J. Huffaker, J. J. Huang et al., Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress, Mol Psychiatry, vol.9, issue.7, p.684, 2004.

O. Robicsek, R. Karry, I. Petit, N. Salman-kesner, F. J. Müller et al., Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients, Mol Psychiatry, vol.18, issue.10, p.1067, 2013.

K. E. Ward, L. Friedman, A. Wise, and S. C. Schulz, Meta-analysis of brain and cranial size in schizophrenia, Schizophr Res, vol.22, pp.197-200, 1996.

L. F. Jarskog, L. A. Glantz, J. H. Gilmore, and J. A. Lieberman, Apoptotic mechanisms in the pathophysiology of schizophrenia, Prog Neuropsychopharmacol Biol Psychiatry, vol.29, issue.5, pp.846-58, 2005.

L. F. Jarskog, E. S. Selinger, J. A. Lieberman, and J. H. Gilmore, Apoptotic proteins in the temporal cortex in schizophrenia: high Bax/Bcl-2 ratio without caspase-3 activation, Am J Psychiatry, vol.161, issue.1, pp.109-124, 2004.

K. Fujise, D. Zhang, J. L. Liu, and E. T. Yeh, Regulation of apoptosis and cell cycle progression by MCL1 differential role of proliferating cell nuclear antigen, J Biol Chem, issue.50, pp.39458-65, 2000.

C. A. Bousman, S. Luza, S. G. Mancuso, D. Kang, C. M. Opazo et al., Elevated biquitinated proteins in brain and blood of individuals with schizophrenia, Sci Rep, vol.9, issue.1, p.2307, 2019.

K. C. Huang, K. C. Yang, H. Lin, T. T. Tsao, and S. A. Lee, Transcriptome alterations of mitochondrial and coagulation function in schizophrenia by cortical sequencing analysis, BMC Genomics, vol.15, issue.9, p.6, 2014.

F. M. Benes, B. Lim, and S. Subburaju, Site-specific regulation of cell cycle and DNA repair in post-mitotic GABA cells in schizophrenic versus bipolars, Proc Natl Acad Sci, vol.106, issue.28, pp.11731-11737, 2009.

K. M. Gill and A. A. Grace, The Role of Neurotransmitters in Schizophrenia, Schizophrenia and Psychotic Spectrum Disorders, pp.153-157, 2016.

S. Matthysse and J. Sugarman, Neurotransmitter Theories of Schizophrenia, Handbook of Psychopharmacology, pp.221-223, 1978.

M. Bencherif, M. K. Stachowiak, A. J. Kucinski, and P. M. Lippiello, Alpha7 nicotinic cholinergic neuromodulation may reconcile multiple neurotransmitter hypotheses of schizophrenia, Med Hypotheses, vol.78, issue.5, pp.594-594, 2012.

N. Müller and M. J. Schwarz, Immune system and Schizophrenia, Immunol Rev, vol.6, pp.213-233, 2010.

M. Reale, A. Patruno, M. A. De-lutiis, M. Pesce, M. Felaco et al., Dysregulation of chemo-cytokine production in schizophrenic patients versus healthy controls, BMC Neurosci, vol.12, issue.1, p.13, 2011.

T. A. Malavia, S. Chaparala, J. Wood, K. Chowdari, K. M. Prasad et al., Generating testable hypotheses for schizophrenia and rheumatoid arthritis pathogenesis by integrating epidemiological, genomic, and protein interaction data, NPJ Schizophr, vol.3, issue.1, p.11, 2017.

J. G. Pouget, V. F. Gonçalves, S. L. Spain, H. K. Finucane, and S. Raychaudhuri, Schizophrenia Working Group of the Psychiatric Genomics Consortium

, Genome-wide association studies suggest limited immune gene enrichment in schizophrenia compared to 5 autoimmune diseases, Schizophr Bull, vol.42, pp.1176-84, 2016.

E. Scarr, M. Udawela, and B. Dean, Changed frontal pole gene expression suggest altered interplay between neurotransmitter, developmental, and inflammatory pathways in schizophrenia, NPJ Schizophr, vol.4, p.4, 2018.

A. S. Lee, D. Jesús-cortés, H. Kabir, Z. D. Knobbe, W. Orr et al., The neuropsychiatric disease-associated gene cacna1c mediates survival of young hippocampal neurons, Eneuro, vol.3, issue.2, pp.6-16, 2016.

M. Maschietto, A. C. Tahira, R. Puga, L. Lima, D. Mariani et al., Co-expression network of neural-differentiation genes shows specific pattern in schizophrenia, BMC Med Genomics, vol.8, issue.1, p.23, 2015.

M. D. Rubio, K. Wood, V. Haroutunian, and J. H. Meador-woodruff, Dysfunction of the ubiquitin proteasome and ubiquitin-like systems in schizophrenia, Neuropsychopharmacology, vol.38, issue.10, p.1910, 2013.

S. T. Narla, Y. W. Lee, C. A. Benson, P. Sarder, K. J. Brennand et al., Common developmental genome deprogramming in schizophrenia-Role of Integrative Nuclear FGFR1 Signaling (INFS), Schizophr Res, vol.185, pp.17-19, 2017.

P. Roussos, A. C. Mitchell, G. Voloudakis, J. F. Fullard, V. M. Pothula et al., A role for noncoding variation in schizophrenia, Cell Rep, vol.9, issue.4, pp.1417-1446, 2014.

G. Chana, C. A. Bousman, T. T. Money, A. Gibbons, P. Gillett et al., Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis, Front Cell Neurosci, vol.7, issue.0, p.95, 2013.

N. Cattane, A. Minelli, E. Milanesi, C. Maj, S. Bignotti et al., Altered gene expression in schizophrenia: findings from transcriptional signatures in fibroblasts and blood, PloS One, vol.10, issue.2, p.116686, 2015.